Both in Pharmaceuticals
Verastem vs Ardelyx
Over the past year VSTM returned −6.6% and ARDX returned −39.5%; their daily moves had a correlation of 0.22.
VSTM −6.6% ARDX −39.5%Growth of $1, one year, split-adjusted
| Metric | VSTM | ARDX |
|---|---|---|
| Price | $8.78 | $3.11 |
| Market cap | $794.7M | $801.7M |
| Today | −4.93% | −5.05% |
| 1 month | +16.2% | −8.1% |
| 6 months | +33.4% | −51.9% |
| Year to date | +13.7% | −46.7% |
| 1 year | −6.6% | −39.5% |
| Revenue growth (YoY) | +1775.4% | +23.8% |
| Gross margin | 89.9% | 95.2% |
| Net margin | −86.5% | −13.8% |
| P/E (TTM) | — | — |
| Price / sales | 9.1× | 1.8× |
| Net cash | $54.6M | $30.0M |
| Dividend yield | — | — |
| Volatility (60d) | 71.3% | 49.5% |
| Short % of float | 17.7% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).